MicroPort Endovascular adjusts share repurchase amid dividend plan

Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd. has announced a differentiated cash dividend of CNY 1.3 per 10 shares (tax inclusive) for the first half of 2025, based on the total share capital after deducting shares held in the company's dedicated repurchase account. This adjustment, approved on August 26, 2025, means repurchased shares will not participate in the dividend distribution, leading to a revised total cash dividend of CNY 157,185,566.20.

The differentiated dividend impacts the company's second phase share repurchase program, initially approved on October 28, 2024. Effective October 17, 2025, the maximum repurchase price has been adjusted from CNY 178.01 per share to CNY 176.73 per share (tax inclusive) following the ex-dividend date. This change maintains the principle of adjusting the repurchase price proportionally for cash dividends.

As of September 30, 2025, MicroPort Endovascular has cumulatively repurchased 1,263,043 shares, representing 1.02% of its total share capital, at a total cost of CNY 132,745,761.84. The repurchase, ranging from CNY 84.26 to CNY 120 per share, is intended for employee stock ownership plans or equity incentives. China International Capital Corporation Limited verified that the differentiated dividend aligns with regulations and does not harm shareholder interests.